Search

Your search keyword '"Cardiomyopathy -- Physiological aspects"' showing total 22 results
Start Over Descriptor "Cardiomyopathy -- Physiological aspects" Topic physiological aspects
22 results on '"Cardiomyopathy -- Physiological aspects"'

1. Myocardial substrate metabolism in the normal and failing heart

Author

Stanley, William C., Recchia, Fabio A., and Lopaschuk, Gary D.

Subjects
Heart diseases -- Physiological aspects, Metabolism -- Physiological aspects, Heart failure -- Physiological aspects, Cardiomyopathy -- Physiological aspects, Biological sciences, Health, Physiological aspects
Abstract

I. Introduction II. Overview of Myocardial Substrate Metabolism A. Regulation of metabolic pathways in the heart B. Carbohydrate metabolism C. Fatty acid metabolism D. Ketone body metabolism E. Interregulation of [...]

Published
2005

2. Maximal exercise tolerance in chronic congestive heart failure: relationship to resting left ventricular function

Author

Carell, Edgar S., Murali, Srinivas, Schulman, Douglas S., Estrada-Quintero, Tulio, and Uretsky, Barry F.

Subjects
Heart diseases -- Physiological aspects, Congestive heart failure -- Physiological aspects, Heart ventricle, Left -- Physiological aspects, Cardiomyopathy -- Physiological aspects, Health, Physiological aspects
Abstract

The relationship between maximal exercise tolerance and resting radionuclide indexes of left ventricular systolic and diastolic function were evaluated in 20 ischemic and 44 idiopathic cardiomyopathy patients with New York [...]

Published
1994

3. The Effect of Cardiomyoplasty on Left Atrial Function in Experimental Canine Models(*)

Author

Ootaki, Yoshio, Okada, Masayoshi, Tsukube, Takuro, and Okita, Yutaka

Subjects
Heart diseases -- Physiological aspects, Natriuretic peptides -- Physiological aspects, Heart enlargement -- Physiological aspects, Cardiomyopathy -- Physiological aspects, Surgery -- Physiological aspects, Health, Physiological aspects
Abstract

Background: Cardiomyoplasty utilizes the latissimus dorsi muscle to boost the failing ventricle. However, the mechanism for clinical improvement still remains controversial. We have previously shown that left ventricular contraction was [...]

Published
2001

4. EXPRESSION OF [A.sub.1B]-ADRENOCEPTOR IS REPRESSED IN HUMAN VENTRICULAR TISSUE OF SPONGIFORM CARDIOMYOPATHY

Author

Yan, Ming, Bird, Phillip I., Dowling, John P., and Lim, Yean Leng

Subjects
Heart diseases -- Physiological aspects, Epinephrine -- Receptors, Cardiomyopathy -- Physiological aspects, Health, Physiological aspects
Abstract

Ming Yan, MD,PhD(*); Phillip I Bird, PhD; John P Dowling, MD and Yean Leng Lim, MD,PhD. Cardiac Research Laboratory, National Heart Centre, Singapore; Department of Medicine, Box Hill Hospital, VIC, [...]

Published
2000

5. The Effect of Coronary Vasospasm on the Direction of ST-Segment Deviation in Patients With Both Hypertrophic Cardiomyopathy and Vasospastic Angina(*)

Author

Kodama, Koji, Shigematsu, Yuji, Hamada, Mareomi, Hiwada, Kunio, Kazatani, Yukio, Matsuzaki, Keisuke, and Murakami, Eiki

Subjects
Heart diseases -- Physiological aspects, Coronary vasospasm -- Physiological aspects, Electrocardiography -- Physiological aspects, Electrocardiogram -- Physiological aspects, Cardiomyopathy -- Physiological aspects, Health, Physiological aspects
Abstract

Background: There has been no report of ECG changes during anginal attacks in patients with coexistent hypertrophic cardiomyopathy (HCM) and vasospastic angina. Study objectives: To elucidate the change in ST-segment [...]

Published
2000

6. Cardiomyocytes infected by Trypanosoma cruzi show myofibril degeneration

Subjects
Heart diseases -- Physiological aspects, Muscle diseases -- Physiological aspects, Parasitic diseases -- Physiological aspects, Heart cells -- Physiological aspects, Cardiomyopathy -- Physiological aspects, Health, Science and technology, Physiological aspects
Abstract

Cardiomyocytes infected by Trypanosoma cruzi show myofibril degeneration rather than a disassembly of the I bands within sarcomeres. According to a study from Brazil, "Infection with Trypanosoma cruzi causes acute [...]

Published
2006

7. Cardiomyocytes infected by Trypanosoma cruzi show myofibril degeneration

Subjects
Heart diseases -- Physiological aspects, Muscle diseases -- Physiological aspects, Parasitic diseases -- Physiological aspects, Heart cells -- Physiological aspects, Cardiomyopathy -- Physiological aspects, Health, Physiological aspects
Abstract

Cardiomyocytes infected by Trypanosoma cruzi show myofibril degeneration rather than a disassembly of the I bands within sarcomeres. According to a study from Brazil, "Infection with Trypanosoma cruzi causes acute [...]

Published
2006

8. Cardiomyocytes infected by Trypanosoma cruzi show myofibril degeneration

Subjects
Physiological aspects, Myocardial diseases -- Physiological aspects, Medical research -- Physiological aspects, Heart cells -- Physiological aspects, Muscular diseases -- Physiological aspects, Heart diseases -- Physiological aspects, Medicine, Experimental -- Physiological aspects, Muscle diseases -- Physiological aspects, Cardiomyopathy -- Physiological aspects
Abstract

Cardiomyocytes infected by Trypanosoma cruzi show myofibril degeneration rather than a disassembly of the I bands within sarcomeres. According to a study from Brazil, 'Infection with Trypanosoma cruzi causes acute [...]

Published
2006

9. Cardiovascular remodeling is reduced by sildenafil in NOS inhibitor-treated rats

Subjects
Heart diseases -- Physiological aspects, Cyclic guanylic acid -- Physiological aspects, Muscle diseases -- Physiological aspects, Heart cells -- Physiological aspects, Cardiomyopathy -- Physiological aspects, Health, Science and technology, Physiological aspects
Abstract

Cardiovascular remodeling associated with hypertensive cardiomyopathy is reduced by sildenafil in NOS inhibitor-treated rats Researchers in Brazil note, "Many of the physiological responses to nitric oxide (NO) are mediated by [...]

Published
2006

10. Cardiovascular remodeling is reduced by sildenafil in NOS inhibitor-treated rats

Subjects
Heart diseases -- Physiological aspects, Cyclic guanylic acid -- Physiological aspects, Muscle diseases -- Physiological aspects, Heart cells -- Physiological aspects, Cardiomyopathy -- Physiological aspects, Hypertension -- Physiological aspects, Health, Physiological aspects
Abstract

Cardiovascular remodeling associated with hypertensive cardiomyopathy is reduced by sildenafil in NOS inhibitor-treated rats Researchers in Brazil note, "Many of the physiological responses to nitric oxide (NO) are mediated by [...]

Published
2006

11. Cardiac functions are altered by deletion of peroxisome proliferator-activated receptor-alpha

Subjects
Heart diseases -- Physiological aspects, Muscle diseases -- Physiological aspects, Cardiomyopathy -- Physiological aspects, Health, Science and technology, Physiological aspects
Abstract

Deletion of peroxisome proliferator-activated receptor-alpha induces an alteration of cardiac functions. Researchers in France report, "The peroxisome proliferator-activated receptor-alpha (PPARalpha) plays a major role in the control of cardiac energy [...]

Published
2006

12. Ethnicity variations in LVM, EDV, and stroke volume are related to abnormal glucose metabolism

Subjects
Wake Forest University, Heart diseases -- Physiological aspects, Medical research -- Physiological aspects, Medicine, Experimental -- Physiological aspects, Stroke (Disease) -- Physiological aspects, Dextrose -- Physiological aspects, Muscle diseases -- Physiological aspects, Diabetes -- Physiological aspects, Glucose -- Physiological aspects, Glucose metabolism -- Physiological aspects, Cardiovascular diseases -- Physiological aspects, Cardiomyopathy -- Physiological aspects, Atherosclerosis -- Physiological aspects, Health, Science and technology, Physiological aspects
Abstract

Ethnicity differences in left ventricular mass, end-diastolic volume, and stroke volume are related to abnormal glucose metabolism independent of subclinical cardiovascular disease. "Studies have demonstrated increased left ventricular mass (LVM) [...]

Published
2006

13. Ethnicity variations in LVM, EDV, and stroke volume are related to abnormal glucose metabolism

Subjects
Wake Forest University, Heart diseases -- Physiological aspects, Medical research -- Physiological aspects, Medicine, Experimental -- Physiological aspects, Stroke (Disease) -- Physiological aspects, Dextrose -- Physiological aspects, Muscle diseases -- Physiological aspects, Diabetes -- Physiological aspects, Glucose -- Physiological aspects, Glucose metabolism -- Physiological aspects, Cardiovascular diseases -- Physiological aspects, Cardiomyopathy -- Physiological aspects, Atherosclerosis -- Physiological aspects, Health, Physiological aspects
Abstract

Ethnicity differences in left ventricular mass, end-diastolic volume, and stroke volume are related to abnormal glucose metabolism independent of subclinical cardiovascular disease. "Studies have demonstrated increased left ventricular mass (LVM) [...]

Published
2006

14. GLP-1 metabolite improves left ventricular performance in dogs with DCM

Subjects
Heart diseases -- Physiological aspects, Dextrose -- Physiological aspects, Metabolites -- Physiological aspects, Glucose -- Physiological aspects, Peptides -- Physiological aspects, Cardiomyopathy -- Physiological aspects, Health, Science and technology, Physiological aspects
Abstract

Active metabolite of GLP-1 mediates myocardial glucose uptake and improves left ventricular performance in dilated cardiomyopathy dog model. "We have shown previously that the glucagon-like peptide-1 (GLP-1)-(7-36) amide increases myocardial [...]

Published
2006

15. GLP-1 metabolite improves left ventricular performance in dogs with DCM

Subjects
Heart diseases -- Physiological aspects, Dextrose -- Physiological aspects, Metabolites -- Physiological aspects, Glucose -- Physiological aspects, Peptides -- Physiological aspects, Cardiomyopathy -- Physiological aspects, Health, Physiological aspects
Abstract

Active metabolite of GLP-1 mediates myocardial glucose uptake and improves left ventricular performance in dilated cardiomyopathy dog model. "We have shown previously that the glucagon-like peptide-1 (GLP-1)-(7-36) amide increases myocardial [...]

Published
2006

16. Patients with IDCM and celiac disease have reduced levels of serum carnitine

Subjects
Heart diseases -- Physiological aspects, Medical research -- Physiological aspects, Medicine, Experimental -- Physiological aspects, Muscle diseases -- Physiological aspects, Carnitine -- Physiological aspects, Cardiomyopathy -- Physiological aspects, Health, Science and technology, Physiological aspects
Abstract

Researchers have investigated carnitine deficiency in patients with coeliac disease and idiopathic dilated cardiomyopathy. Scientists in Italy report, "Idiopathic dilated cardiomyopathy (IDCM) and coeliac disease (CD) are two pathological conditions [...]

Published
2005

17. Patients with IDCM and celiac disease have reduced levels of serum carnitine

Subjects
Heart diseases -- Physiological aspects, Muscle diseases -- Physiological aspects, Carnitine -- Physiological aspects, Cardiomyopathy -- Physiological aspects, Health, Physiological aspects
Abstract

Researchers have investigated carnitine deficiency in patients with coeliac disease and idiopathic dilated cardiomyopathy. Scientists in Italy report, "Idiopathic dilated cardiomyopathy (IDCM) and coeliac disease (CD) are two pathological conditions [...]

Published
2005

18. Hepatocyte growth factor ameliorates cardiac dysfunction in hamster hearts

Subjects
Heart diseases -- Physiological aspects, Muscle diseases -- Physiological aspects, Cardiomyopathy -- Physiological aspects, Hamsters -- Physiological aspects, Health, Science and technology, Diseases, Physiological aspects
Abstract

Hepatocyte growth factor ameliorates cardiac dysfunction in hamster hearts. "Structural remodeling of the myocardium, including myocyte hypertrophy, myocardial fibrosis, and dilatation, drives functional impairment in various forms of acquired and [...]

Published
2005

19. Hepatocyte growth factor ameliorates cardiac dysfunction in hamster hearts

Subjects
Heart diseases -- Physiological aspects, Muscle diseases -- Physiological aspects, Cardiomyopathy -- Physiological aspects, Hamsters -- Physiological aspects, Health, Diseases, Physiological aspects
Abstract

Hepatocyte growth factor ameliorates cardiac dysfunction in hamster hearts. "Structural remodeling of the myocardium, including myocyte hypertrophy, myocardial fibrosis, and dilatation, drives functional impairment in various forms of acquired and [...]

Published
2005

20. Researchers shed light on the mechanisms of lipotoxic cardiomyopathy

Subjects
Heart diseases -- Physiological aspects, Muscle diseases -- Physiological aspects, Diabetes -- Physiological aspects, Phosphatases -- Physiological aspects, Cardiomyopathy -- Physiological aspects, Health, Science and technology, Physiological aspects
Abstract

Researchers in Texas explain how protein phosphatase 2C (PP2C) and 5'-AMP-activated kinase play a role in lipotoxic cardiomyopathy. According to recent research published in the American Journal of Physiology - [...]

Published
2005

21. Researchers shed light on the mechanisms of lipotoxic cardiomyopathy

Subjects
Heart diseases -- Physiological aspects, Muscle diseases -- Physiological aspects, Diabetes -- Physiological aspects, Phosphatases -- Physiological aspects, Cardiomyopathy -- Physiological aspects, Health, Physiological aspects
Abstract

Researchers in Texas explain how protein phosphatase 2C (PP2C) and 5'-AMP-activated kinase play a role in lipotoxic cardiomyopathy. According to recent research published in the American Journal of Physiology - [...]

Published
2005

22. Molecular mechanisms of heart muscle disease

Author

Lewis, William and Papoian, Thomas

Subjects
Heart diseases -- Physiological aspects, Doxorubicin -- Physiological aspects, Cardiomyopathy -- Physiological aspects, Health, Physiological aspects
Abstract

Molecular Mechanisms of Heart Muscle Disease SUBCELLULAR MECHANISMS of dilated heart muscle disease (congestive cardiomyopathy) are poorly understood. With the development of techniques of molecular biology, some causal events in [...]

Published
1991

Catalog

Books, media, physical & digital resources
See catalog results